Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Assets Average (2018 - 2021)

Cogent Biosciences (COGT) has 4 years of Assets Average data on record, last reported at $222.0 million in Q3 2021.

  • For Q3 2021, Assets Average rose 159.71% year-over-year to $222.0 million; the TTM value through Sep 2021 reached $222.0 million, up 159.71%, while the annual FY2020 figure was $150.2 million, 121.9% up from the prior year.
  • Assets Average reached $222.0 million in Q3 2021 per COGT's latest filing, down from $233.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $244.3 million in Q1 2021 and bottomed at $35.0 million in Q2 2020.
  • Average Assets Average over 4 years is $114.1 million, with a median of $84.5 million recorded in 2019.
  • Peak YoY movement for Assets Average: crashed 53.52% in 2020, then surged 565.95% in 2021.
  • A 4-year view of Assets Average shows it stood at $90.4 million in 2018, then plummeted by 40.62% to $53.7 million in 2019, then skyrocketed by 264.18% to $195.4 million in 2020, then rose by 13.59% to $222.0 million in 2021.
  • Per Business Quant database, its latest 3 readings for Assets Average were $222.0 million in Q3 2021, $233.1 million in Q2 2021, and $244.3 million in Q1 2021.